Flu surge boosts demand for medications and diagnostics in South Korea Flu season drives sharp rise in pharmaceutical sales ...

Speaking about the surging demand for Xofluza, Sun Boyang, a pharmacist at Peking University People's Hospital, told China Central Television that compared with another common flu medication called ...

Recalling the success achieved in 2024, Singh said there has been a series of indigenous development including India’s first ...

Botulinum toxin is under clinical development by Huons and currently in Phase III for Unspecified Musculoskeletal Disorders.

Various reports in the Chinese media highlight how the emergency departments, infectious disease units, fever clinics, and ...

INR:9437. ka chart dikhaiye Why did Borri Biopharma’s mass production of remdesivir attract regulatory attention? The top 100 private healthcare companies in ...